Dutch health tech firm Aidence has raised €2.25 million in seed round from henQ, Northzone, and Health Innovations.

Aidence develops AI-based imaging software for the healthcare industry for faster diagnosing of x-ray, MRI, and CT images. The company claims its computer-aided diagnostics software makes diagnoses cheaper and more accurate with “human-level accuracy” that will address the shortage of radiologists.

“The promise of AI has been there for decades but only now are we finally capable of fulfilling it. We are convinced that Artificial Intelligence will improve patients’ lives by increasing the number of early and accurate cancer diagnoses,” said CEO Mark-Jan Harte. “It will also benefit the medical specialists who are performing imaging diagnostics by reducing their workload and providing a never-tiring second reader.”

It will bring its lung nodule detection product to market next, he added.

The new funds will be invested in sales and tech teams as well as expanding globally. The company is currently exploring more ways of applying its deep learning technology to other medical uses including chest CT pathologies, MR imaging, and triaging.

“We are impressed with what Mark-Jan and his team have built, and are excited to partner with them to build the diagnostics products of the future,” said Coen van Duiven, partner at henQ, on the investment.

Comments are closed.